LoginSignup
image de profil
BamBamInvest
@BamBamInvest
1Sem.·

Highlights Q4 Earnings Intuitive Surgical

$ISRG (-0,9 %)

attachment


  • Sales: USD 2.41 billion (estimated USD 2.24 billion); increase of +25 % compared to the previous year
  • Earnings per share: USD 2.21 (estimated USD 1.75); increase of +38% compared to the previous year
  • Net profit (non-GAAP): USD 805 million (increase of 40% compared to the previous year)


Segment sales:


Instruments and accessories:


  • Sales: USD 1.41 billion (estimated USD 1.35 billion) ; increase of 23% compared to the previous year
  • The growth is due to an 18% increase in da Vinci procedure volume and a 70% increase in ion procedure volume.


System sales:

  • Sales: $655 million (estimated $536.22 million) ; 36% increase over prior year
  • Includes 493 da Vinci surgical systems placed, an increase of 415 over the prior year.


Revenue from services:

  • Sales: USD 346 million (estimated USD 346.12 million)


Operating Highlights:


  • Global da Vinci processes: Growth of +18% year-on-year in the fourth quarter of 2024.
  • Da Vinci Surgical System placements: 493 systems, including 174 da Vinci 5 systems; installed base increased to 9,902 (up 15% year-on-year).
  • Operating income (non-GAAP): $928 million (49% increase over prior year).
  • Operating income (GAAP): USD 735 million (increase of 63 % compared to the previous year).


Forecast 2025:


  • Global growth in da Vinci procedures: 13-16% (growth in 2024: 17%)
  • Non-GAAP gross margin: 67-68% (2024: 69.1%) .
  • Growth in operating costs: 10-15 % (2024: 10 %) .


Cash flow and financial health:

  • Cash, cash equivalents and investments: USD 8.83 billion (increase of USD 521 million compared to the previous quarter) .
  • Free cash flow: USD 878 million (estimated USD 878 million) .


CEO's comment:


  • "Strong growth in procedures driven by the continued rollout of the da Vinci system and the increased number of Ion procedures. We have significantly expanded our installed base, ensuring broader access to minimally invasive care."


Further insights:


  • Foundation contributions: USD 45 million in Q4 2024 (compared to USD 40 million in the previous year).
  • Leasing trends: Increase in systems leased on a usage basis (140 systems in Q4 2024 compared to 109 in the previous year)
  • R&D investments: Focus on developing advanced robotics and expanding system accessibility.


#earnings
#quartalszahlen

9
8 Commentaires
Chris@Multibagger
1Sem.
For me, the most exciting company in the Medtec sector. Unfortunately, it has recently performed too well for a current entry. If it comes back, it's definitely worth considering. Either via a savings plan or a derivative with an endless term.
•
1
•
image de profil
BamBamInvest@BamBamInvest
1Sem.
@Multibagger I already had them in my portfolio, but unfortunately my position was far too small, which is why I sold them when they doubled. This is one of the reasons why I only build up larger positions in established companies.
••
Chris@Multibagger
1Sem.
@BamBamInvest Are you probably not a fan of savings plans on individual shares? Otherwise, another idea would be to increase the initially small position on a monthly basis. That's what I do with Biontech and a few investments in the commodities sector, for example.
•
1
•
image de profil
BamBamInvest@BamBamInvest
1Sem.
@Multibagger This is not possible with flatex Austria and all Austrian banks. Only on ETF . Trade Republic , Scalable not yet tax-simple and I don't want to do that to myself 😄 That's why I only build up 1-2 % positions with 10X candidates who can also manage this over 3-5 years.
••
Chris@Multibagger
1Sem.
@BamBamInvest This is also not possible with flatex Germany. I do it with TR and the ones that don't work with Consors, even if it costs fees there. I'm still looking for a provider where I can save without fees. They are just not Amazons etc.
•
1
•
image de profil
BamBamInvest@BamBamInvest
1Sem.
@Multibagger In time this will also come in Austria, apparently Trade Republic is to become tax-simple this year, then flatex will have to do something, otherwise it will be dangerous. I don't know the fees in Germany, but at flatex you can buy anything, you can find pretty much any stock / fund and the fees are manageable, especially since I don't buy anything under 500 euros anyway and then only if I don't have more capital available, it usually has to be 1500 plus. But yes, I would probably buy in several tranches if it only costs me 1 euro, I can hit flatex 5-8 times 😄
••
Chris@Multibagger
1Sem.
@BamBamInvest flatex does not offer any share savings plans here. But they are very cheap for US stock exchanges. 5.90 is a real bargain for the NASDAQ. I'm working on trading the derivatives for at least 500. Then I can get the ones from JPM and MS that I trade most often at flatex for 0,--, because they are platinum partners. Unfortunately, you can't trade the two issuers at TR.
•
1
•
image de profil
BamBamInvest@BamBamInvest
1Sem.
@Multibagger nasdaq and co here with us 15.90 and then they also earn from the spread conversion rate. Austria is much smaller and since little is happening due to regulation and co, it would be refreshing if someone cleaned up 😄
••
Participez à la conversation
S'inscrireConnexion